About
At the frontier of neurogenetics and neuroimmunology
Rooted in a legacy of excellence in neurogenetics, CMN is expanding its reach with a renewed focus on neuroimmunology. Together, these two axes define our center’s evolving identity and scientific direction.
We investigate the molecular causes of complex diseases of the brain and nervous system, including Alzheimer’s, frontotemporal dementia, epilepsy, ALS, and peripheral neuropathies. Our researchers combine insights from genetics and immunology with functional biology, patient-derived models, and next-generation technologies to understand disease—and transform that understanding into action.
Our strengths
- A world-class neurogenetics track record built on decades of patient partnerships and discovery
- Leading expertise in neuroimmunology
- An expansive biobank and unique patient cohorts, from rare disorders to healthy aging
- A culture of collaboration across labs, disciplines, and borders
At CMN, our mission is to uncover the mechanisms of neurological disease and help forge a future where those insights lead to better diagnosis, better treatments, and better lives.